tony, I gave my guess as what the MMs would due after the approval, based in part by the fact that it appeared that many day traders had bought LGND in anticipation of the approvals that came this week. I have never indicated that the MMs actions to find buyers and sellers was in any way sinister, that's just the way things work.
Discussing LGND's price with you is absurd, because you think than that LGND's price has gone down since the drugs were approved, when in fact the price has gone up (slightly overall, but hitting $13 on both days that the approvals were announced).
You have had problems looking at data (clinical or market price) AFTER the fact, so there is no use discussing FUTURE price action with you. In case you haven't noticed, I actively try to avoid responding directly to your posts, which have been virtually unchanged for almost two years now.
The major shakeout that I predicted at $16 was a bit more major than I expected, but I consider a price drop from $16 to 5 1/2 as a MAJOR shakeout, which I was expecting, but not quite as severe as had happened (and I also expected the price to rebound after the shakeout, which of course it did, rather sharply). |
